AMG 732 clinical trials

An Open-Label, Rollover Study for Participants With Thyroid Eye Disease Previously Enrolled in Amgen-Sponsored AMG 732 Studies and are Primary Proptosis Non-responders or who Relapsed During the Safety Follow-up

This study is for people with Thyroid Eye Disease who previously took part in a trial for the drug AMG 732 but didn't see enough improvement in their bulging eyes or whose condition returned. It aims to see if continued treatment with AMG 732 can help further.